Equity Overview
Price & Market Data
Price: $15.40
Daily Change: -$0.02 / 0.13%
Daily Range: $15.39 - $16.68
Market Cap: $848,024,576
Daily Volume: 1,183,264
Performance Metrics
1 Week: 10.10%
1 Month: -8.78%
3 Months: -0.58%
6 Months: 41.24%
1 Year: 12.01%
YTD: -8.02%
Company Details
Employees: 55
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.